Ilosure 4 Tablet contains Iloperidone 4 mg, an atypical antipsychotic indicated for the treatment of schizophrenia in adults. Iloperidone acts by modulating the activity of dopamine D2 and serotonin 5-HT2A receptors, which are implicated in the pathophysiology of schizophrenia. This medication helps to reduce symptoms such as hallucinations, delusions, disorganized thinking, and emotional withdrawal, thereby improving overall patient functioning and quality of life. Ilosure 4 is typically initiated at a low dose and gradually titrated to minimize adverse effects, including orthostatic hypotension, dizziness, and sedation. It is essential to monitor patients for signs of extrapyramidal symptoms, metabolic changes, and potential cardiac effects such as QT interval prolongation. Iloperidone should be used with caution in patients with a history of cardiovascular disease, seizures, or hepatic impairment. Concomitant use with other central nervous system depressants may enhance sedative effects. Regular follow-up and adherence to prescribed dosing are critical to achieving optimal therapeutic outcomes. Ilosure 4 Tablet should be prescribed and administered under the supervision of a qualified healthcare professional, with consideration given to individual patient needs and potential drug interactions.